Alzamend Share Price
NASDAQ: ALZN | Micro Cap | Healthcare$0.76
+$0.76 (--%) Last updated on 21 Nov, 2026 | 02:29 ISTAlzamend Stock Performance
Alzamend Share Price Chart
$0.87$0.89
L
H
Alzamend Quarterly Profit & Loss
All figures in USD
Alzamend Annual Profit & Loss
All figures in USD
Alzamend Balance Sheet
All figures in USD Million
Alzamend Cash Flow
Annually
All figures in USD Million
Corporate Actions
About Alzamend
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.
Alzamend Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.22 | $0.87 | -30.87% |
Oct 2026 | $1.54 | $1.26 | -29.21% |
Sep 2026 | $1.64 | $1.78 | +17.11% |
Aug 2026 | $1.33 | $1.52 | +19.69% |
Jul 2026 | $1.30 | $1.27 | +1.60% |
Jun 2026 | $1.22 | $1.25 | +5.93% |
May 2026 | $1.05 | $1.18 | +9.77% |
Apr 2026 | $1.02 | $1.07 | +0.47% |
Mar 2026 | $1.96 | $1.07 | -45.96% |
Feb 2026 | $2.19 | $1.98 | -6.60% |
Jan 2026 | $1.97 | $2.12 | +21.14% |
Dec 2025 | $2.16 | $1.75 | -17.45% |